Staidson (Beijing) BioPharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wang Chao
Chief executive officer
CN¥1.4m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.08% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) Stock Rockets 47% As Investors Are Less Pessimistic Than Expected
Oct 08
Subdued Growth No Barrier To Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) With Shares Advancing 26%
Aug 03There's Reason For Concern Over Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s (SZSE:300204) Massive 26% Price Jump
Aug 02What Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s (SZSE:300204) 25% Share Price Gain Is Not Telling You
Mar 18CEO
Wang Chao (42 yo)
3.3yrs
Tenure
CN¥1,362,100
Compensation
Mr. Wang Chao is General Manager of Staidson (Beijing) BioPharmaceuticals Co. Ltd. from August 2021.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 15.5yrs | CN¥1.30m | 1.1% CN¥ 40.5m | |
| Supervisor | 13.8yrs | CN¥168.10k | no data | |
| Chairman of Supervisory Board | 6.2yrs | CN¥240.00k | 0.098% CN¥ 3.6m | |
| Non-Independent Director | 6.2yrs | CN¥1.70m | 0.21% CN¥ 7.6m | |
| Non-Independent Director | 3.3yrs | CN¥1.60m | 0.075% CN¥ 2.8m | |
| Independent Director | 3.3yrs | CN¥136.80k | no data | |
| Independent Director | 3.3yrs | CN¥136.80k | no data | |
| Employee Supervisor | 3.3yrs | no data | 0.024% CN¥ 883.2k | |
| Director | 2.2yrs | no data | no data |
3.3yrs
Average Tenure
59yo
Average Age
Experienced Board: 300204's board of directors are considered experienced (3.3 years average tenure).